Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug;33(15):1893-901.
doi: 10.1093/eurheartj/ehs114. Epub 2012 Jun 17.

Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes

Affiliations
Review

Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes

Issa J Dahabreh et al. Eur Heart J. 2012 Aug.

Abstract

Aims: Randomized controlled trials (RCTs) are the gold standard for assessing the efficacy of therapeutic interventions because randomization protects from biases inherent in observational studies. Propensity score (PS) methods, proposed as a potential solution to confounding of the treatment-outcome association, are widely used in observational studies of therapeutic interventions for acute coronary syndromes (ACS). We aimed to systematically assess agreement between observational studies using PS methods and RCTs on therapeutic interventions for ACS.

Methods and results: We searched for observational studies of interventions for ACS that used PS methods to estimate treatment effects on short- or long-term mortality. Using a standardized algorithm, we matched observational studies to RCTs based on patients' characteristics, interventions, and outcomes ('topics'), and we compared estimates of treatment effect between the two designs. When multiple observational studies or RCTs were identified for the same topic, we performed a meta-analysis and used the summary relative risk for comparisons. We matched 21 observational studies investigating 17 distinct clinical topics to 63 RCTs (median = 3 RCTs per observational study) for short-term (7 topics) and long-term (10 topics) mortality. Estimates from PS analyses differed statistically significantly from randomized evidence in two instances; however, observational studies reported more extreme beneficial treatment effects compared with RCTs in 13 of 17 instances (P = 0.049). Sensitivity analyses limited to large RCTs, and using alternative meta-analysis models yielded similar results.

Conclusion: For the treatment of ACS, observational studies using PS methods produce treatment effect estimates that are of more extreme magnitude compared with those from RCTs, although the differences are rarely statistically significant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Search strategy flow. ACS, acute coronary syndromes; CAD, coronary artery disease; PS, propensity score; RCTs, randomized controlled trials.
Figure 2
Figure 2
(A) Relative risks from randomized controlled trials (white diamonds) and observational studies using propensity score methods (red squares), reporting on long-term mortality. When more than two randomized or observational studies were available for a topic, estimates were obtained from random-effects meta-analysis. (B) Corresponding relative effect sizes (black squares) comparing the effect sizes from randomized and propensity-based observational studies on long-term mortality. In both panels, extending lines denote 95% confidence intervals of estimates. See Supplementary material online, Table S1 for detailed study-level information. Please see Table 1 for abbreviation definitions.
Figure 3
Figure 3
(A) Relative risks from randomized controlled trials (white diamonds) and observational studies using propensity score methods (red squares), reporting on short-term mortality. (B) Corresponding relative effect sizes (black squares) comparing the relative risks from randomized trials and observational studies using propensity score methods. Layout is similar to Figure 2. Arrows indicate lower or upper bounds of confidence intervals that were outside the plotted range of values. See Supplementary material online, Table S1 for detailed study-level information. Please see Table 1 for abbreviation definitions.

Comment in

References

    1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, De Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209. - PMC - PubMed
    1. Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009;302:2254–2256. - PMC - PubMed
    1. Rosenbaum PR. Observational Studies. 2nd ed. New York, USA: Springer; 2002.
    1. Byar DP. Why databases should not replace randomized clinical trials. Biometrics. 1980;36:337–342. - PubMed
    1. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892. - PMC - PubMed

MeSH terms